Volver a Agenda
Session 4, Track C: Pharmacovigilance Unleashed: Unlocking PV Best Practices through KPIs and Data Mining
Session Chair(s)
Mei Lam, BSN, RN
Canada PV Manager/Safety Regional Country Contact
Haleon, Canada
Vanessa Zapata
Associate Director, Regional Pharmacovigilance Officer
Merck Canada Inc., Canada
This game-changing session will unravel the secrets of effective key performance indicators (KPIs) and their powerful application in the realm of pharmacovigilance. Industry experts will provide a deep dive into innovative solutions that seamlessly support pharmacovigilance integration activities during company acquisitions and product in-licensing deal. Additionally, the session offers exclusive insights from a health agency perspective on KPIs, providing a comprehensive understanding of this critical aspect of pharmacovigilance.
Learning Objective : - Analyze the critical role of Key Performance Indicators (KPIs) in optimizing pharmacovigilance processes
-
Demonstrate the application of data mining techniques to uncover valuable insights and drive informed decision-making in pharmacovigilance activities
- Evaluate strategies for seamlessly integrating pharmacovigilance operations during company acquisitions and product in-licensing deals, aligning with industry best practices
Speaker(s)
Innovative Solutions to Support PV Integration Activities in Company Acquisitions and Product In-license Deals
Stephanie Stankiewicz
Merck Sharp & Dohme LLC, United States
Associate Director, Drug Safety
Effective KPIs and their application in PV
Manar Hammood, MSc
Zenith PV, Canada, Canada
Founder and Director of PV Operations
¿Tiene una cuenta?